Advertisement

Index by author

April 01, 2013; Volume 83,Issue 4

A

  1. Akinaga, Juliana

    1. Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline
      Juliana Akinaga, Vanessa Lima, Luiz Ricardo de Almeida Kiguti, Flávia Hebeler-Barbosa, Rocío Alcántara-Hernández, J. Adolfo García-Sáinz and André Sampaio Pupo
      Molecular Pharmacology April 2013, 83 (4) 870-881; DOI: https://doi.org/10.1124/mol.112.082313

  2. Alcántara-Hernández, Rocío

    1. Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline
      Juliana Akinaga, Vanessa Lima, Luiz Ricardo de Almeida Kiguti, Flávia Hebeler-Barbosa, Rocío Alcántara-Hernández, J. Adolfo García-Sáinz and André Sampaio Pupo
      Molecular Pharmacology April 2013, 83 (4) 870-881; DOI: https://doi.org/10.1124/mol.112.082313

B

  1. Baird, Barbara

    1. Inhibitors of PI(4,5)P2 Synthesis Reveal Dynamic Regulation of IgE Receptor Signaling by Phosphoinositides in RBL Mast Cells
      Marcela de Souza Santos, Rose Mary Zumstein Georgetto Naal, Barbara Baird and David Holowka
      Molecular Pharmacology April 2013, 83 (4) 793-804; DOI: https://doi.org/10.1124/mol.112.082834

  2. Bangasser, Debra

    1. Sex-Biased Stress Signaling: The Corticotropin-Releasing Factor Receptor as a Model
      Rita J. Valentino, Debra Bangasser and Elisabeth J. Van Bockstaele
      Molecular Pharmacology April 2013, 83 (4) 737-745; DOI: https://doi.org/10.1124/mol.112.083550

  3. Barber, Thomas D.

    1. Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling
      Jessica L. Esseltine, Melinda D. Willard, Isabella H. Wulur, Mary E. Lajiness, Thomas D. Barber and Stephen S. G. Ferguson
      Molecular Pharmacology April 2013, 83 (4) 770-780; DOI: https://doi.org/10.1124/mol.112.081695

  4. Beinborn, Martin

    1. Membrane Tethered Bursicon Constructs as Heterodimeric Modulators of the Drosophila G Protein–Coupled Receptor Rickets
      Benjamin N. Harwood, Jean-Philippe Fortin, Kevin Gao, Ci Chen, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology April 2013, 83 (4) 814-821; DOI: https://doi.org/10.1124/mol.112.081570

  5. Bueno, Ana B.

    1. Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
      Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos and Patrick M. Sexton
      Molecular Pharmacology April 2013, 83 (4) 822-834; DOI: https://doi.org/10.1124/mol.112.084525

C

  1. Casás-Selves, Matias

    1. A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
      Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás-Selves, Clark Hatheway, Aik Choon Tan, James DeGregori and Lynn E. Heasley
      Molecular Pharmacology April 2013, 83 (4) 882-893; DOI: https://doi.org/10.1124/mol.112.084111

  2. Chavkin, Charles

    1. Dynorphin–Still an Extraordinarily Potent Opioid Peptide
      Charles Chavkin
      Molecular Pharmacology April 2013, 83 (4) 729-736; DOI: https://doi.org/10.1124/mol.112.083337

  3. Chen, Ci

    1. Membrane Tethered Bursicon Constructs as Heterodimeric Modulators of the Drosophila G Protein–Coupled Receptor Rickets
      Benjamin N. Harwood, Jean-Philippe Fortin, Kevin Gao, Ci Chen, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology April 2013, 83 (4) 814-821; DOI: https://doi.org/10.1124/mol.112.081570

  4. Chen, Wen-Shu

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  5. Chen, Yun-Ju

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  6. Christopoulos, Arthur

    1. Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
      Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos and Patrick M. Sexton
      Molecular Pharmacology April 2013, 83 (4) 822-834; DOI: https://doi.org/10.1124/mol.112.084525

  7. Conn, P. J.

    1. A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
      M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
      Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891

  8. Cox, Brian

    1. Avram Goldstein: The Founder of Molecular Pharmacology
      Brian Cox, Ji-Sheng Han and Ray Dingledine
      Molecular Pharmacology April 2013, 83 (4) 720-722; DOI: https://doi.org/10.1124/mol.112.084640

  9. Cox, Brian M.

    1. Recent Developments in the Study of Opioid Receptors
      Brian M. Cox
      Molecular Pharmacology April 2013, 83 (4) 723-728; DOI: https://doi.org/10.1124/mol.112.083279

D

  1. DeGregori, James

    1. A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
      Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás-Selves, Clark Hatheway, Aik Choon Tan, James DeGregori and Lynn E. Heasley
      Molecular Pharmacology April 2013, 83 (4) 882-893; DOI: https://doi.org/10.1124/mol.112.084111

  2. Dingledine, Ray

    1. Avram Goldstein: The Founder of Molecular Pharmacology
      Brian Cox, Ji-Sheng Han and Ray Dingledine
      Molecular Pharmacology April 2013, 83 (4) 720-722; DOI: https://doi.org/10.1124/mol.112.084640

  3. Dingledine, Raymond

    1. Ionotropic Glutamate Receptors: Regulation by G-Protein-Coupled Receptors
      Asheebo Rojas and Raymond Dingledine
      Molecular Pharmacology April 2013, 83 (4) 746-752; DOI: https://doi.org/10.1124/mol.112.083352

  4. Duvernay, Matthew

    1. Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
      Matthew Duvernay, Summer Young, David Gailani, Jonathan Schoenecker and Heidi E. Hamm
      Molecular Pharmacology April 2013, 83 (4) 781-792; DOI: https://doi.org/10.1124/mol.112.083477

E

  1. Esseltine, Jessica L.

    1. Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling
      Jessica L. Esseltine, Melinda D. Willard, Isabella H. Wulur, Mary E. Lajiness, Thomas D. Barber and Stephen S. G. Ferguson
      Molecular Pharmacology April 2013, 83 (4) 770-780; DOI: https://doi.org/10.1124/mol.112.081695

F

  1. Ferguson, Stephen S. G.

    1. Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling
      Jessica L. Esseltine, Melinda D. Willard, Isabella H. Wulur, Mary E. Lajiness, Thomas D. Barber and Stephen S. G. Ferguson
      Molecular Pharmacology April 2013, 83 (4) 770-780; DOI: https://doi.org/10.1124/mol.112.081695

  2. Fortin, Jean-Philippe

    1. Membrane Tethered Bursicon Constructs as Heterodimeric Modulators of the Drosophila G Protein–Coupled Receptor Rickets
      Benjamin N. Harwood, Jean-Philippe Fortin, Kevin Gao, Ci Chen, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology April 2013, 83 (4) 814-821; DOI: https://doi.org/10.1124/mol.112.081570

G

  1. Gailani, David

    1. Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
      Matthew Duvernay, Summer Young, David Gailani, Jonathan Schoenecker and Heidi E. Hamm
      Molecular Pharmacology April 2013, 83 (4) 781-792; DOI: https://doi.org/10.1124/mol.112.083477

  2. Gao, Kevin

    1. Membrane Tethered Bursicon Constructs as Heterodimeric Modulators of the Drosophila G Protein–Coupled Receptor Rickets
      Benjamin N. Harwood, Jean-Philippe Fortin, Kevin Gao, Ci Chen, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology April 2013, 83 (4) 814-821; DOI: https://doi.org/10.1124/mol.112.081570

  3. García-Sáinz, J. Adolfo

    1. Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline
      Juliana Akinaga, Vanessa Lima, Luiz Ricardo de Almeida Kiguti, Flávia Hebeler-Barbosa, Rocío Alcántara-Hernández, J. Adolfo García-Sáinz and André Sampaio Pupo
      Molecular Pharmacology April 2013, 83 (4) 870-881; DOI: https://doi.org/10.1124/mol.112.082313

  4. Garg, Vivek

    1. ICA-105574 Interacts with a Common Binding Site to Elicit Opposite Effects on Inactivation Gating of EAG and ERG Potassium Channels
      Vivek Garg, Anna Stary-Weinzinger and Michael C. Sanguinetti
      Molecular Pharmacology April 2013, 83 (4) 805-813; DOI: https://doi.org/10.1124/mol.112.084384

  5. Giembycz, Mark A.

    1. Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease
      Thunicia Moodley, Sylvia M. Wilson, Taruna Joshi, Christopher F. Rider, Pawan Sharma, Dong Yan, Robert Newton and Mark A. Giembycz
      Molecular Pharmacology April 2013, 83 (4) 894-906; DOI: https://doi.org/10.1124/mol.112.083493

  6. Gregory, K. J.

    1. A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
      M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
      Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891

H

  1. Hamm, Heidi E.

    1. Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
      Matthew Duvernay, Summer Young, David Gailani, Jonathan Schoenecker and Heidi E. Hamm
      Molecular Pharmacology April 2013, 83 (4) 781-792; DOI: https://doi.org/10.1124/mol.112.083477

  2. Han, Ji-Sheng

    1. Avram Goldstein: The Founder of Molecular Pharmacology
      Brian Cox, Ji-Sheng Han and Ray Dingledine
      Molecular Pharmacology April 2013, 83 (4) 720-722; DOI: https://doi.org/10.1124/mol.112.084640

  3. Harwood, Benjamin N.

    1. Membrane Tethered Bursicon Constructs as Heterodimeric Modulators of the Drosophila G Protein–Coupled Receptor Rickets
      Benjamin N. Harwood, Jean-Philippe Fortin, Kevin Gao, Ci Chen, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology April 2013, 83 (4) 814-821; DOI: https://doi.org/10.1124/mol.112.081570

  4. Hatheway, Clark

    1. A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
      Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás-Selves, Clark Hatheway, Aik Choon Tan, James DeGregori and Lynn E. Heasley
      Molecular Pharmacology April 2013, 83 (4) 882-893; DOI: https://doi.org/10.1124/mol.112.084111

  5. Heasley, Lynn E.

    1. A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
      Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás-Selves, Clark Hatheway, Aik Choon Tan, James DeGregori and Lynn E. Heasley
      Molecular Pharmacology April 2013, 83 (4) 882-893; DOI: https://doi.org/10.1124/mol.112.084111

  6. Hebeler-Barbosa, Flávia

    1. Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline
      Juliana Akinaga, Vanessa Lima, Luiz Ricardo de Almeida Kiguti, Flávia Hebeler-Barbosa, Rocío Alcántara-Hernández, J. Adolfo García-Sáinz and André Sampaio Pupo
      Molecular Pharmacology April 2013, 83 (4) 870-881; DOI: https://doi.org/10.1124/mol.112.082313

  7. Hinz, Trista K.

    1. A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
      Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás-Selves, Clark Hatheway, Aik Choon Tan, James DeGregori and Lynn E. Heasley
      Molecular Pharmacology April 2013, 83 (4) 882-893; DOI: https://doi.org/10.1124/mol.112.084111

  8. Hollenberg, Paul F.

    1. Formation, Reactivity, and Antiplatelet Activity of Mixed Disulfide Conjugates of Clopidogrel
      Haoming Zhang, D. Adam Lauver, Benedict R. Lucchesi and Paul F. Hollenberg
      Molecular Pharmacology April 2013, 83 (4) 848-856; DOI: https://doi.org/10.1124/mol.112.084392

  9. Holowka, David

    1. Inhibitors of PI(4,5)P2 Synthesis Reveal Dynamic Regulation of IgE Receptor Signaling by Phosphoinositides in RBL Mast Cells
      Marcela de Souza Santos, Rose Mary Zumstein Georgetto Naal, Barbara Baird and David Holowka
      Molecular Pharmacology April 2013, 83 (4) 793-804; DOI: https://doi.org/10.1124/mol.112.082834

  10. Hsia, Te-Chun

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  11. Hsu, Sheng-Chie

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  12. Huang, Chih-Yang

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  13. Huang, Tzung-Chi

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  14. Huang, Wei-Chien

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  15. Hung, Mien-Chie

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

J

  1. Jarvis, Michael F.

    1. P2X Receptors as Drug Targets
      R. Alan North and Michael F. Jarvis
      Molecular Pharmacology April 2013, 83 (4) 759-769; DOI: https://doi.org/10.1124/mol.112.083758

  2. Joshi, Taruna

    1. Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease
      Thunicia Moodley, Sylvia M. Wilson, Taruna Joshi, Christopher F. Rider, Pawan Sharma, Dong Yan, Robert Newton and Mark A. Giembycz
      Molecular Pharmacology April 2013, 83 (4) 894-906; DOI: https://doi.org/10.1124/mol.112.083493

K

  1. Kiguti, Luiz Ricardo de Almeida

    1. Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline
      Juliana Akinaga, Vanessa Lima, Luiz Ricardo de Almeida Kiguti, Flávia Hebeler-Barbosa, Rocío Alcántara-Hernández, J. Adolfo García-Sáinz and André Sampaio Pupo
      Molecular Pharmacology April 2013, 83 (4) 870-881; DOI: https://doi.org/10.1124/mol.112.082313

  2. Kim, Jihye

    1. A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
      Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás-Selves, Clark Hatheway, Aik Choon Tan, James DeGregori and Lynn E. Heasley
      Molecular Pharmacology April 2013, 83 (4) 882-893; DOI: https://doi.org/10.1124/mol.112.084111

  3. Kopin, Alan S.

    1. Membrane Tethered Bursicon Constructs as Heterodimeric Modulators of the Drosophila G Protein–Coupled Receptor Rickets
      Benjamin N. Harwood, Jean-Philippe Fortin, Kevin Gao, Ci Chen, Martin Beinborn and Alan S. Kopin
      Molecular Pharmacology April 2013, 83 (4) 814-821; DOI: https://doi.org/10.1124/mol.112.081570

L

  1. Lajiness, Mary E.

    1. Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling
      Jessica L. Esseltine, Melinda D. Willard, Isabella H. Wulur, Mary E. Lajiness, Thomas D. Barber and Stephen S. G. Ferguson
      Molecular Pharmacology April 2013, 83 (4) 770-780; DOI: https://doi.org/10.1124/mol.112.081695

  2. Lauver, D. Adam

    1. Formation, Reactivity, and Antiplatelet Activity of Mixed Disulfide Conjugates of Clopidogrel
      Haoming Zhang, D. Adam Lauver, Benedict R. Lucchesi and Paul F. Hollenberg
      Molecular Pharmacology April 2013, 83 (4) 848-856; DOI: https://doi.org/10.1124/mol.112.084392

  3. Leslie, Frances M.

    1. Nicotinic Receptors in Addiction Pathways
      Frances M. Leslie, Celina Y. Mojica and Daisy D. Reynaga
      Molecular Pharmacology April 2013, 83 (4) 753-758; DOI: https://doi.org/10.1124/mol.112.083659

  4. Lima, Vanessa

    1. Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline
      Juliana Akinaga, Vanessa Lima, Luiz Ricardo de Almeida Kiguti, Flávia Hebeler-Barbosa, Rocío Alcántara-Hernández, J. Adolfo García-Sáinz and André Sampaio Pupo
      Molecular Pharmacology April 2013, 83 (4) 870-881; DOI: https://doi.org/10.1124/mol.112.082313

  5. Lindsley, C. W.

    1. A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
      M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
      Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891

  6. Lucchesi, Benedict R.

    1. Formation, Reactivity, and Antiplatelet Activity of Mixed Disulfide Conjugates of Clopidogrel
      Haoming Zhang, D. Adam Lauver, Benedict R. Lucchesi and Paul F. Hollenberg
      Molecular Pharmacology April 2013, 83 (4) 848-856; DOI: https://doi.org/10.1124/mol.112.084392

M

  1. Manka, J. T.

    1. A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
      M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
      Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891

  2. Marek, Lindsay A.

    1. A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
      Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás-Selves, Clark Hatheway, Aik Choon Tan, James DeGregori and Lynn E. Heasley
      Molecular Pharmacology April 2013, 83 (4) 882-893; DOI: https://doi.org/10.1124/mol.112.084111

  3. Mojica, Celina Y.

    1. Nicotinic Receptors in Addiction Pathways
      Frances M. Leslie, Celina Y. Mojica and Daisy D. Reynaga
      Molecular Pharmacology April 2013, 83 (4) 753-758; DOI: https://doi.org/10.1124/mol.112.083659

  4. Moodley, Thunicia

    1. Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease
      Thunicia Moodley, Sylvia M. Wilson, Taruna Joshi, Christopher F. Rider, Pawan Sharma, Dong Yan, Robert Newton and Mark A. Giembycz
      Molecular Pharmacology April 2013, 83 (4) 894-906; DOI: https://doi.org/10.1124/mol.112.083493

N

  1. Naal, Rose Mary Zumstein Georgetto

    1. Inhibitors of PI(4,5)P2 Synthesis Reveal Dynamic Regulation of IgE Receptor Signaling by Phosphoinositides in RBL Mast Cells
      Marcela de Souza Santos, Rose Mary Zumstein Georgetto Naal, Barbara Baird and David Holowka
      Molecular Pharmacology April 2013, 83 (4) 793-804; DOI: https://doi.org/10.1124/mol.112.082834

  2. Newton, Robert

    1. Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease
      Thunicia Moodley, Sylvia M. Wilson, Taruna Joshi, Christopher F. Rider, Pawan Sharma, Dong Yan, Robert Newton and Mark A. Giembycz
      Molecular Pharmacology April 2013, 83 (4) 894-906; DOI: https://doi.org/10.1124/mol.112.083493

  3. Niswender, C. M.

    1. A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
      M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
      Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891

  4. Noetzel, M. J.

    1. A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
      M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
      Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891

  5. North, R. Alan

    1. P2X Receptors as Drug Targets
      R. Alan North and Michael F. Jarvis
      Molecular Pharmacology April 2013, 83 (4) 759-769; DOI: https://doi.org/10.1124/mol.112.083758

P

  1. Pupo, André Sampaio

    1. Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline
      Juliana Akinaga, Vanessa Lima, Luiz Ricardo de Almeida Kiguti, Flávia Hebeler-Barbosa, Rocío Alcántara-Hernández, J. Adolfo García-Sáinz and André Sampaio Pupo
      Molecular Pharmacology April 2013, 83 (4) 870-881; DOI: https://doi.org/10.1124/mol.112.082313

R

  1. Reynaga, Daisy D.

    1. Nicotinic Receptors in Addiction Pathways
      Frances M. Leslie, Celina Y. Mojica and Daisy D. Reynaga
      Molecular Pharmacology April 2013, 83 (4) 753-758; DOI: https://doi.org/10.1124/mol.112.083659

  2. Rider, Christopher F.

    1. Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease
      Thunicia Moodley, Sylvia M. Wilson, Taruna Joshi, Christopher F. Rider, Pawan Sharma, Dong Yan, Robert Newton and Mark A. Giembycz
      Molecular Pharmacology April 2013, 83 (4) 894-906; DOI: https://doi.org/10.1124/mol.112.083493

  3. Rojas, Asheebo

    1. Ionotropic Glutamate Receptors: Regulation by G-Protein-Coupled Receptors
      Asheebo Rojas and Raymond Dingledine
      Molecular Pharmacology April 2013, 83 (4) 746-752; DOI: https://doi.org/10.1124/mol.112.083352

S

  1. Sanguinetti, Michael C.

    1. ICA-105574 Interacts with a Common Binding Site to Elicit Opposite Effects on Inactivation Gating of EAG and ERG Potassium Channels
      Vivek Garg, Anna Stary-Weinzinger and Michael C. Sanguinetti
      Molecular Pharmacology April 2013, 83 (4) 805-813; DOI: https://doi.org/10.1124/mol.112.084384

  2. Santos, Marcela de Souza

    1. Inhibitors of PI(4,5)P2 Synthesis Reveal Dynamic Regulation of IgE Receptor Signaling by Phosphoinositides in RBL Mast Cells
      Marcela de Souza Santos, Rose Mary Zumstein Georgetto Naal, Barbara Baird and David Holowka
      Molecular Pharmacology April 2013, 83 (4) 793-804; DOI: https://doi.org/10.1124/mol.112.082834

  3. Savage, Emilia E.

    1. Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
      Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos and Patrick M. Sexton
      Molecular Pharmacology April 2013, 83 (4) 822-834; DOI: https://doi.org/10.1124/mol.112.084525

  4. Schoenecker, Jonathan

    1. Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
      Matthew Duvernay, Summer Young, David Gailani, Jonathan Schoenecker and Heidi E. Hamm
      Molecular Pharmacology April 2013, 83 (4) 781-792; DOI: https://doi.org/10.1124/mol.112.083477

  5. Sexton, Patrick M.

    1. Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
      Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos and Patrick M. Sexton
      Molecular Pharmacology April 2013, 83 (4) 822-834; DOI: https://doi.org/10.1124/mol.112.084525

  6. Sharma, Pawan

    1. Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease
      Thunicia Moodley, Sylvia M. Wilson, Taruna Joshi, Christopher F. Rider, Pawan Sharma, Dong Yan, Robert Newton and Mark A. Giembycz
      Molecular Pharmacology April 2013, 83 (4) 894-906; DOI: https://doi.org/10.1124/mol.112.083493

  7. Singleton, Katherine R.

    1. A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
      Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás-Selves, Clark Hatheway, Aik Choon Tan, James DeGregori and Lynn E. Heasley
      Molecular Pharmacology April 2013, 83 (4) 882-893; DOI: https://doi.org/10.1124/mol.112.084111

  8. Sloop, Kyle W.

    1. Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
      Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos and Patrick M. Sexton
      Molecular Pharmacology April 2013, 83 (4) 822-834; DOI: https://doi.org/10.1124/mol.112.084525

  9. Stary-Weinzinger, Anna

    1. ICA-105574 Interacts with a Common Binding Site to Elicit Opposite Effects on Inactivation Gating of EAG and ERG Potassium Channels
      Vivek Garg, Anna Stary-Weinzinger and Michael C. Sanguinetti
      Molecular Pharmacology April 2013, 83 (4) 805-813; DOI: https://doi.org/10.1124/mol.112.084384

  10. Stauffer, S. R.

    1. A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
      M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
      Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891

T

  1. Tan, Aik Choon

    1. A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
      Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás-Selves, Clark Hatheway, Aik Choon Tan, James DeGregori and Lynn E. Heasley
      Molecular Pharmacology April 2013, 83 (4) 882-893; DOI: https://doi.org/10.1124/mol.112.084111

  2. Tsai, Shing-Ling

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  3. Tu, Chih-Yen

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

V

  1. Valentino, Rita J.

    1. Sex-Biased Stress Signaling: The Corticotropin-Releasing Factor Receptor as a Model
      Rita J. Valentino, Debra Bangasser and Elisabeth J. Van Bockstaele
      Molecular Pharmacology April 2013, 83 (4) 737-745; DOI: https://doi.org/10.1124/mol.112.083550

  2. Van Bockstaele, Elisabeth J.

    1. Sex-Biased Stress Signaling: The Corticotropin-Releasing Factor Receptor as a Model
      Rita J. Valentino, Debra Bangasser and Elisabeth J. Van Bockstaele
      Molecular Pharmacology April 2013, 83 (4) 737-745; DOI: https://doi.org/10.1124/mol.112.083550

  3. Vinson, P. N.

    1. A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
      M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
      Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891

W

  1. Wei, Ya-Ling

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  2. Willard, Francis S.

    1. Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
      Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos and Patrick M. Sexton
      Molecular Pharmacology April 2013, 83 (4) 822-834; DOI: https://doi.org/10.1124/mol.112.084525

  3. Willard, Melinda D.

    1. Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling
      Jessica L. Esseltine, Melinda D. Willard, Isabella H. Wulur, Mary E. Lajiness, Thomas D. Barber and Stephen S. G. Ferguson
      Molecular Pharmacology April 2013, 83 (4) 770-780; DOI: https://doi.org/10.1124/mol.112.081695

  4. Wilson, Sylvia M.

    1. Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease
      Thunicia Moodley, Sylvia M. Wilson, Taruna Joshi, Christopher F. Rider, Pawan Sharma, Dong Yan, Robert Newton and Mark A. Giembycz
      Molecular Pharmacology April 2013, 83 (4) 894-906; DOI: https://doi.org/10.1124/mol.112.083493

  5. Wootten, Denise

    1. Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
      Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos and Patrick M. Sexton
      Molecular Pharmacology April 2013, 83 (4) 822-834; DOI: https://doi.org/10.1124/mol.112.084525

  6. Wulur, Isabella H.

    1. Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling
      Jessica L. Esseltine, Melinda D. Willard, Isabella H. Wulur, Mary E. Lajiness, Thomas D. Barber and Stephen S. G. Ferguson
      Molecular Pharmacology April 2013, 83 (4) 770-780; DOI: https://doi.org/10.1124/mol.112.081695

X

  1. Xiang, Z.

    1. A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
      M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
      Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891

Y

  1. Yan, Dong

    1. Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease
      Thunicia Moodley, Sylvia M. Wilson, Taruna Joshi, Christopher F. Rider, Pawan Sharma, Dong Yan, Robert Newton and Mark A. Giembycz
      Molecular Pharmacology April 2013, 83 (4) 894-906; DOI: https://doi.org/10.1124/mol.112.083493

  2. Yeh, Ming-Hsin

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  3. Yen, Chia-Jui

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  4. Young, Summer

    1. Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
      Matthew Duvernay, Summer Young, David Gailani, Jonathan Schoenecker and Heidi E. Hamm
      Molecular Pharmacology April 2013, 83 (4) 781-792; DOI: https://doi.org/10.1124/mol.112.083477

  5. Yu, Meng-Chieh

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

  6. Yu, Yung-Luen

    1. Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
      Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
      Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743

Z

  1. Zhang, Haoming

    1. Formation, Reactivity, and Antiplatelet Activity of Mixed Disulfide Conjugates of Clopidogrel
      Haoming Zhang, D. Adam Lauver, Benedict R. Lucchesi and Paul F. Hollenberg
      Molecular Pharmacology April 2013, 83 (4) 848-856; DOI: https://doi.org/10.1124/mol.112.084392
Back to top

In this issue

Advertisement